Effectiveness of pregabalin for treatment of chronic cervical radiculopathy with upper limb radiating pain: an 8-week, multicenter prospective observational study in Japanese primary care settings
Open Access
- 1 May 2019
- journal article
- research article
- Published by Taylor & Francis Ltd in Journal of Pain Research
- Vol. ume 12, 1411-1424
- https://doi.org/10.2147/jpr.s191906
Abstract
Background: Despite high prevalence of chronic neck pain in Japan and the negative impact pain has on patient’s quality of life (QoL), the therapeutic value of pregabalin for chronic neck pain with a neuropathic pain (NeP) component has not been assessed in a typical Japanese health care setting. Methods: An 8-week, non-interventional, multicenter, observational study of Japanese adults (≥20 years) with chronic refractory cervical pain including a NeP element (for ≥12 weeks) and sleep disturbance on the Pain-Related Sleep-Interference Scale (PRSIS) ≥1 (from 0 “does not interfere with sleep” to 10 “completely interferes”). Patients received either usual care with conventional analgesics or pregabalin (150–600 mg/day) for 8 weeks. “Usual care” with analgesics or other treatment(s) was determined based on physician’s best clinical judgment. Primary endpoint was change from baseline to week 8 in PRSIS. Secondary endpoints included: change from baseline to week 4 in PRSIS, and to week 4 and 8 in pain Numerical Rating Scale (NRS; from 0 “no pain” to 10 “worst possible pain”), and on the Neck Disability Index (NDI). Other assessments of QoL were undertaken. Safety was monitored. Results: Overall, 369 patients received pregabalin (n=145) or usual care (n=224). The median (range) dose of pregabalin was 49.6 (25.0–251.5) mg/day. Least-squares mean change in PRSIS from baseline to week 8 favored pregabalin (–1.167 vs –0.269; treatment difference –0.898 [95% CI –1.262, –0.535], PPPConclusion: In this open-label study, pregabalin improved PRSIS and resulted in clinically meaningful reductions in pain in Japanese patients with NeP associated with chronic cervical pain. ClinicalTrials.gov identifier: NCT02868359.Keywords
This publication has 40 references indexed in Scilit:
- Neuropathic Pain Components Are Common in Patients With Painful Cervical Radiculopathy, but Not in Patients With Nonspecific Neck-Arm PainThe Clinical Journal of Pain, 2013
- Associations between neck and shoulder pain (called katakori in Japanese) and sagittal spinal alignment parameters among the general populationJournal of Orthopaedic Science, 2013
- Validity, reliability and responsiveness of the Japanese version of the Neck Disability IndexJournal of Orthopaedic Science, 2013
- Pregabalin Treatment for Peripheral Neuropathic PainDrug Safety, 2012
- Characteristics of neck and shoulder pain (called katakori in Japanese) among members of the nursing staffJournal of Orthopaedic Science, 2012
- Effect of Pregabalin in the Treatment of Refractory Neck Pain: Cost and Clinical Evidence from Medical Practice in Orthopedic Surgery and Rehabilitation ClinicsPain Practice, 2010
- Recommendations for the Pharmacological Management of Neuropathic Pain: An Overview and Literature UpdateMayo Clinic Proceedings, 2010
- Patient-reported-outcomes in subjects with painful lumbar or cervical radiculopathy treated with pregabalin: evidence from medical practice in primary care settingsRheumatology International, 2009
- The Burden and Determinants of Neck Pain in WorkersSpine, 2008
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990